WindRose Health Investors Recapitalizes RevHealth

WindRose Health Investors Recapitalizes Lykan Bioscience Holdings

June 4, 2019

Biotechnology

WindRose Health Investors completed an equity recapitalization of Lykan Bioscience Holdings, LLC, a Hopkinton, Massachusetts-based contract manufacturing services organization focused on cell and gene therapy production and logistics. The investment provides capital to support growth and the build-out of a 60,000+ square foot cGMP facility to expand manufacturing capacity; terms were not disclosed.

WindRose Health Investors Recapitalizes Healthmap Solutions

May 21, 2019

Healthcare Services

WindRose Health Investors completed an $85 million equity recapitalization of Healthmap Solutions to provide growth capital and support the company's expansion into new markets. Healthmap, a specialty population health management firm focused on kidney disease, will continue to be led by CEO Joe Vattamattam and COO & Founder Andrew Wall.

WindRose Health Investors Recapitalizes Veristat Group Inc.

April 7, 2021

Healthcare Services

WindRose Health Investors completed an equity recapitalization of Veristat Group Inc., a global clinical research organization, with Veristat management retaining a significant minority stake. The investment will provide capital and strategic resources to support Veristat's growth and expansion across clinical development, regulatory affairs, biostatistics, data management and pharmacovigilance; terms were not disclosed.

WindRose Health Investors Recapitalizes Traditions Behavioral Health

November 14, 2018

Healthcare Services

Funds managed by WindRose Health Investors completed a recapitalization of Traditions Behavioral Health (TBH), a West Coast provider of permanent outsourced physician psychiatric services. WindRose partnered with TBH's executive team (founder and CEO Gary A. Hayes remains in place) to provide growth capital to expand into new U.S. markets, broaden services and increase its network of psychiatrists.

WindRose Health Investors Recapitalizes Terrapin Pharmacy

January 5, 2022

Healthcare Services

WindRose Health Investors completed a recapitalization of Terrapin Pharmacy LLC, a closed-door specialty pharmacy serving behavioral health and long-term care populations in the Mid-Atlantic. The investment provides growth capital to support geographic expansion and increased market share; terms were not disclosed.

WindRose Health Investors Recapitalizes Bluestone Physician Services

April 14, 2021

Healthcare Services

WindRose Health Investors completed an equity recapitalization of Bluestone Physician Services to provide growth capital and support expansion. Bluestone — a provider of on-site primary care, care coordination, and behavioral health services for high-risk, geriatric and disabled patients — will continue to be led by founder Dr. Todd Stivland, who and the executive team retain a significant minority stake.